Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies.
about
Current status of vaccines for schistosomiasisHepatobiliary SchistosomiasisRecent advances in Schistosoma genomicsSchistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infectionCrystal structure and immunological properties of the first annexin from Schistosoma mansoni: insights into the structural integrity of the schistosomal tegumentSchistosomiasis vaccines: where do we stand?Eliminating Schistosomes through Vaccination: What are the Best Immune Weapons?Anti-schistosomal intervention targets identified by lifecycle transcriptomic analysesDNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge InfectionExploring molecular variation in Schistosoma japonicum in ChinaSchistosoma mansoni Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection.Schistosoma mansoni host-exposed surface antigens characterized by sera and recombinant antibodies from schistosomiasis-resistant rats.Schistosoma japonicum UDP-glucose 4-epimerase protein is located on the tegument and induces moderate protection against challenge infection.Schistosoma japonicum tegumental protein 20.8, role in reproduction through its calcium binding ability.Sm29, but not Sm22.6 retains its ability to induce a protective immune response in mice previously exposed to a Schistosoma mansoni infection.Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection modelOf monkeys and men: immunomic profiling of sera from humans and non-human primates resistant to schistosomiasis reveals novel potential vaccine candidates.Human IgG1 Responses to Surface Localised Schistosoma mansoni Ly6 Family Members Drop following Praziquantel Treatment.New Recombinant Mycobacterium bovis BCG Expression Vectors: Improving Genetic Control over Mycobacterial PromotersLysosome-associated membrane glycoprotein (LAMP)--preliminary study on a hidden antigen target for vaccination against schistosomiasisSchistosoma mansoni Infection of Mice, Rats and Humans Elicits a Strong Antibody Response to a Limited Number of Reduction-Sensitive Epitopes on Five Major Tegumental Membrane Proteins.Recombinant vaccines and the development of new vaccine strategies.Functional genes and proteins of Clonorchis sinensis.Novel immunomic technologies for schistosome vaccine development.Genome mining offers a new starting point for parasitology research.Antibody Signatures Reflect Different Disease Pathologies in Patients With Schistosomiasis Due to Schistosoma japonicum.Successful detection, expression and purification of the alternatively spliced truncated Sm14 antigen of an Egyptian strain of Schistosoma mansoni.Recent advances in proteomic applications for schistosomiasis research: potential clinical impact.Epitopes rationally selected through computational analyses induce T-cell proliferation in mice and are recognized by serum from individuals infected with Schistosoma mansoni.Biochemical and immunological characterization of annexin B30 from Clonorchis sinensis excretory/secretory products.The developing schistosome worms elicit distinct immune responses in different tissue regions.Patterns of gene expression in schistosomes: localization by whole mount in situ hybridization.The Use of Reverse Vaccinology and Molecular Modeling Associated with Cell Proliferation Stimulation Approach to Select Promiscuous Epitopes from Schistosoma mansoni.A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice.Extracellular vesicles induce protective immunity against Trichuris muris.Schistosoma mansoni antigens modulate the allergic response in a murine model of ovalbumin-induced airway inflammationA Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against Reinfection in Mice
P2860
Q24657733-BD831278-D6BD-4266-921E-E7E4F2B425E6Q26781791-0121C9FD-603E-42C7-ADF5-3C436327790AQ26829720-6C709419-DA82-4C57-BFFE-728AADE8039BQ27306926-48F81AB3-A6F9-434F-A990-0D6E05D8AB42Q27688900-DA890427-AC31-4AF5-9FB7-0E351BBC7A5AQ28066042-7EB2F3FB-C32A-48CE-ACD3-E09D68FCA5E9Q28081158-1C6C592E-4040-4662-B88A-A290B6CD9372Q28471672-F0F1BA06-0E42-4685-90D4-8DE3296F09F6Q28547011-EC6F504F-1748-4E82-9618-5B6C65DD17E6Q28606875-CFC81904-75CF-4DEE-8A61-C7C6B9AF5303Q33531748-06AD75EF-0EAF-4D11-92D2-9CAC293EC1BBQ33624607-EC4D989C-CE3F-4A24-AB5B-FCCB94EF5754Q34359443-D586BE9A-FA64-48A4-AD70-08A2673DB73CQ35052806-994019D7-C1B9-4FE5-BB84-3409408A09ECQ35130094-D9539D30-5552-4BB9-97F8-3EBEA3DCE714Q35319744-2797DFC9-7D79-43A1-AC71-ADE52A42F67BQ35569944-4581B76F-D01B-4A7E-B6DF-DCA5BF8319AAQ35684066-C9BEEE6F-33D6-4B7C-B73C-44ED1E33BA5DQ35916250-913E47E6-EF79-41AB-B347-E3591FA7F660Q36168215-4808E6FE-9B6E-4156-BC30-D99A2A22185EQ36251172-F39446B0-B94A-44BD-B414-19B58C99A24CQ37370940-E508B1A5-C013-48B7-8CC4-4E68CD341BA9Q37403181-530FEDA0-1138-4CD6-AD67-F1C297065A2CQ38001044-09EDD0BE-63FC-467D-B135-B619F447BEF5Q38309107-70554875-16E8-4B7A-A79B-3AD9B247B2A0Q38978099-F65E632E-17A8-47A3-9FD3-BA5F0FE46940Q38996628-69E3C9D3-6E6B-421A-A8B3-E0046E6458F2Q39034549-7B078905-0B14-4B95-9605-19ED28E3DAD5Q40266719-375E7615-B5FB-454F-9E42-654473B564B6Q44573573-10413DCE-C553-492F-B3D4-58533A19FEBAQ45880012-1C391862-F6B9-4966-AE89-87A232E1570EQ50683654-882657C2-999B-4BCA-A7CF-DE9112F63221Q50869625-B0CB181D-E4DE-48FC-9865-14AA4BA999DCQ51740553-6BE10E28-2238-4BD9-87CB-C33662E07BA1Q54216084-4D12124D-4CA8-4038-B3AB-0C4B2FB8E227Q59098741-FA2E6052-6E52-4FA8-A164-8D480D52BBDBQ59137480-0412CF21-9D0D-4B14-B1FF-F684F20BF34D
P2860
Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Human antibody responses of pa ...... ified through genomic studies.
@ast
Human antibody responses of pa ...... ified through genomic studies.
@en
type
label
Human antibody responses of pa ...... ified through genomic studies.
@ast
Human antibody responses of pa ...... ified through genomic studies.
@en
prefLabel
Human antibody responses of pa ...... ified through genomic studies.
@ast
Human antibody responses of pa ...... ified through genomic studies.
@en
P2860
P50
P1476
Human antibody responses of pa ...... tified through genomic studies
@en
P2093
S C Oliveira
P2860
P304
P356
10.1111/J.1365-2249.2006.03081.X
P577
2006-06-01T00:00:00Z